60505-4512 : Gefitinib 250 mg Oral Tablet
NDC: | 60505-4512 |
Labeler: | Apotex Corp. |
Product Type: | Human Prescription Drug |
Drug Name: | Gefitinib |
Dosage Form: | Oral Tablet |
Application #: | ANDA209532 |
Rev. Date: |
NDC Package Codes:
- 60505-4512-3: 30 TABLET IN 1 BOTTLE (60505‑4512‑3)
Active Ingredients:
- Gefitinib
Dosage Strength:
- 250 mg
Pharmaceutical Classes:
- Kinase Inhibitor [EPC]
- Protein Kinase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0480-4053 Gefitinib 250 mg Oral Tablet, Film Coated by Teva Pharmaceuticals, Inc.
- 50742-366 Gefitinib 250 mg Oral Tablet, Coated by Ingenus Pharmaceuticals, LLC
- 67184-0531 Gefitinib 250 mg Oral Tablet, Coated by Qilu Pharmaceutical Co., Ltd.
- 69339-168 Gefitinib 250 mg Oral Tablet, Film Coated by Dash Pharmaceuticals LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 60505-4505Next: 60505-4517 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.